Kimmich, C., Terzer, T., Benner, A., Dittrich, T., Veelken, K., Carpinteiro, A., . . . Schönland, S. (2020). Daratumumab for systemic AL amyloidosis: Prognostic factors and adverse outcome with nephrotic-range albuminuria. Blood, 135(18), . https://doi.org/10.1182/blood.2019003633
Chicago Style (17th ed.) CitationKimmich, Christoph, et al. "Daratumumab for Systemic AL Amyloidosis: Prognostic Factors and Adverse Outcome with Nephrotic-range Albuminuria." Blood 135, no. 18 (2020). https://doi.org/10.1182/blood.2019003633.
MLA (9th ed.) CitationKimmich, Christoph, et al. "Daratumumab for Systemic AL Amyloidosis: Prognostic Factors and Adverse Outcome with Nephrotic-range Albuminuria." Blood, vol. 135, no. 18, 2020, https://doi.org/10.1182/blood.2019003633.
Warning: These citations may not always be 100% accurate.